Instituto de Diagnostico S.A.

As of June 30, 2026, Instituto de Diagnostico S.A. carries a market capitalization of 408.63B, placing it among publicly traded companies globally. Its enterprise value stands at 521.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Instituto de Diagnostico S.A. has 155.30M shares outstanding.

As of June 30, 2026, Instituto de Diagnostico S.A. trades at a trailing price-to-earnings ratio of 32.24. The price-to-sales ratio is 1.42, and the price-to-book ratio stands at 1.83.

As of June 30, 2026, Instituto de Diagnostico S.A. trades at an EV/EBITDA multiple of 21.45 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 35.08 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 521.01B versus a market cap of 408.63B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Instituto de Diagnostico S.A. maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 55.78, indicating elevated leverage, while an interest coverage ratio of 3.36 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. posted a return on equity (ROE) of 7.51, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 3.38, measuring how efficiently the asset base is converted into earnings. The company generates approximately 93.43M in revenue per employee across its workforce of 3,071.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 68.98 indicates how many times Instituto de Diagnostico S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. recorded an income tax benefit of -430.75M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 12.25B, leaving 12.68B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Instituto de Diagnostico S.A.'s stock has declined approximately 8.63% over the past 52 weeks. The 50-day moving average sits at 2,542.22, while the 200-day moving average is 2,622.60.

Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. generated 286.93B in revenue and converted that into 12.68B in net income, yielding earnings per share of 81.62. EBITDA reached 24.29B, while operating income came in at 14.85B.

As of June 30, 2026, Instituto de Diagnostico S.A. holds 12.33B in cash and equivalents against 124.72B in total debt, resulting in a net debt position of 98.96B. Total book value stands at 223.59B, with working capital of -2.39B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. posted a gross margin of 25.91, reflecting its pricing power and cost economics. The operating margin of 5.18 and net profit margin of 4.42 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Instituto de Diagnostico S.A. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -2.42, meaning Instituto de Diagnostico S.A. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Instituto de Diagnostico S.A.'s most recent stock split took place on September 15, 2026 with a 951:965 split ratio.

As of June 30, 2026, Instituto de Diagnostico S.A. has an Altman Z-Score of 2.06, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.